Compare Part 11 scope guidance and 21 CFR Part 11
How to read this page
- How they are linked says why these two documents are connected. Links explained
- Side by side places facts from each record together, so you can see status, weight and dates at a glance.
- It does not compare content. It does not say which is stricter. Read the official texts for that.
How they are linked
- Part 11 scope guidance interprets 21 CFR Part 11 · Source Unverified link
Side by side
| Part 11 scope guidance | 21 CFR Part 11 | |
|---|---|---|
| Authority | FDA | FDA |
| Legal weight | Guidance & Q&A | Law & regulation |
| Status | Final | In force |
| Last verified | Not yet | Not yet |
| Summary | FDA guidance on how it applies Part 11. FDA says it will not enforce certain requirements on validation, audit trails, record retention and record copying, and sets criteria for legacy systems. Part 11 remains in effect, and predicate rule requirements still apply. | The US regulation setting the conditions under which FDA treats electronic records and signatures as equivalent to paper records and handwritten signatures: validation, audit trails, access controls, record protection and signature controls. |
| Lifecycle |
|
|
| Source | Official text Source: FDA. Public domain. | Official text Source: FDA. Public domain. |
These facts are placed side by side from each record. This page does not say which is stricter or whether requirements differ. Read the official texts.